Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
This grant opportunity aims to support research on new and innovative ideas about emerging risk factors—biological, environmental, and social—and how they interact with known risk factors, like viral hepatitis, to contribute to liver cancer development in the U.S.
Source
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
-
Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
National Institutes of Health
-
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Institutes of Health
-
DoW Toxic Exposures Investigator Initiated Research Award
Dept. of the Army -- USAMRAA
-
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
National Institutes of Health ▸ National Institute on Alcohol Abuse and Alcoholism
-
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers